Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PENG vs AQLB for Total Hip Replacement in Elderly
NCT06679764Phase 4Completed
- Sponsor
- Cairo University
- Start
- May 2022
- Primary completion
- Sep 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised trial of bupivacaine in postoperative pain, sponsored by Cairo University. Primary endpoint: Total amount of morphine consumption at 24 hours. Started May 2022; status: completed.
02
Drugs
bupivacaine
03
Conditions
postoperative pain
Beyond the preview
Go deeper on NCT06679764.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06679764.